financetom
Business
financetom
/
Business
/
Applovin Insider Sold Shares Worth $17,578,120, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Applovin Insider Sold Shares Worth $17,578,120, According to a Recent SEC Filing
Sep 5, 2025 2:36 PM

05:12 PM EDT, 09/05/2025 (MT Newswires) -- Victoria Valenzuela, Chief Administrative & Legal Officer, & Corporate Secretary, on September 04, 2025, sold 35,000 shares in Applovin ( APP ) for $17,578,120. Following the Form 4 filing with the SEC, Valenzuela has control over a total of 269,955 Class A common shares of the company, with 269,955 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1751008/000156218025006124/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US CFPB settles with MoneyLion as enforcement activity winds down
US CFPB settles with MoneyLion as enforcement activity winds down
Nov 21, 2025
* MoneyLion accused of overcharging military personnel on loans * Settlement includes $1.75 million payout * MoneyLion' disagreed with allegations, pleased to settle By Jonathan Stempel NEW YORK, Nov 21 (Reuters) - The U.S. Consumer Financial Protection Bureau reached a $1.75 million settlement with MoneyLion to settle charges that the online lender overcharged military personnel on loans, in possibly one...
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,082,986, According to a Recent SEC Filing
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,082,986, According to a Recent SEC Filing
Nov 21, 2025
05:43 PM EST, 11/21/2025 (MT Newswires) -- Carole Huntsman, Chief Commercial Officer, on November 21, 2025, sold 1,958 shares in Madrigal Pharmaceuticals ( MDGL ) for $1,082,986. Following the Form 4 filing with the SEC, Huntsman has control over a total of 10,032 common shares of the company, with 10,032 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/xslF345X05/wk-form4_1763764773.xml ...
United Therapeutics Insider Sold Shares Worth $3,812,082, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $3,812,082, According to a Recent SEC Filing
Nov 21, 2025
05:34 PM EST, 11/21/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 20, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,812,082. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled indirectly. SEC...
Bill Ackman eyes IPO of hedge fund Pershing in early 2026, FT reports
Bill Ackman eyes IPO of hedge fund Pershing in early 2026, FT reports
Nov 21, 2025
(Reuters) -Billionaire investor Bill Ackman is aiming to publicly list hedge fund company, Pershing Square Capital Management, early next year, the Financial Times reported on Friday, citing two people briefed on the matter. Talks for the listing are at a preliminary stage and could ultimately be delayed or not lead to a public offering depending on the market conditions, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved